Scientists might all learn something from this list, representing as it does how our everyday work is perceived by a small sample of bright youngsters. Alongside several words that could just as well have been listed 100 years ago (such as acid/base, magnetism, mole, scientific method), I was struck by the number of terms hinging on ethical issues in medicine and biology (6%), the theory of evolution (5%) and clinical terminology (5%). The Internet too is up there among giant scientific words such as 'Universe' and 'atom'.
This thought-provoking collection of words suggests that, as working scientists, we need to care at least as much about science education as we do about publication. 682-685; 2008 ) raises issues about the use of mouse models of disease that go well beyond the field of neurodegenerative disorders. As a former head of atherosclerosis research at GlaxoSmithKline laboratories, I can attest that the situation is similar for models of atherosclerosis and dyslipidaemia.
Marco Prunotto
Informed users of mouse models are well aware of their limitations in relation to human pathology, so their expectations from drug studies and the relevance of these to humans are tailored accordingly. But it seems to me that, beyond this relatively small group of practitioners, wider concerns arise.
These might be viewed as a criticism of the rigour of much of the dialogue between preclinical and clinical research. One is about overuse of the glib term "animal model of disease X", which raises expectations and clouds proper interrogation of experiments. As you suggest, it is better to consider a mouse model as primarily one of mechanism and to make a reasoned extrapolation to humans from there.
This approach links in more closely with the current critical preoccupation with translational research. Another concern is one that permeates all science, namely the tendency to regard the model (in whatever form it is expressed) as being identical to its prototype, often coupled with the idea of a 'complete explanation', which is, of course, illusory. Animal studies are not always well designed and null results are rarely published. The standards should be raised to be comparable to those already established in clinical research. Preclinical research projects using animals should be prospectively registered and systematically reviewed. Also, they should be properly designed by using randomization, adequate sample sizes and blinding for evaluation of outcome.
Keith Suckling
Any rigorous scientific research requires investigators to set their basic hypotheses in the context of what is already published, to avoid unnecessary replication and to justify the new study. However, there is often a failure in animal research to apply these standards. This can expose research volunteers and patients to flawed and inadequate research and put biotech investors at risk of substantial long-term financial loss.
Supporting the introduction of these requirements for animal research would improve the body of evidence available to policymakers and investors with regard to human health. It would also minimize wastage of laboratory animals and improve patient safety.
